Data from October 2025 to March 2026.
The challenge
Woodbury Surgery is a small rural general practice, with medicines monitoring led by a clinical pharmacist working alongside a team of two GP partners, nurses, healthcare assistants, and administrators. Before Abtrace, DOAC monitoring was managed through manual electronic health record searches, register building, and patient recalls. As the practice looked to make this process more consistent and easier to manage, it wanted a more automated approach that reduced time spent building patient lists and checking monitoring statuses, allowing staff to focus more on patients who needed more intensive reviews and follow-up for their long term conditions.
The solution
Woodbury Surgery implemented Abtrace's Proactive Monitoring Tool through a pharmacist-led rollout, with searches and recalls set up in around two weeks and embedded into practice workflows within two months. Automated searches created clear patient lists, making it easier to track progress and review outstanding monitoring.
Patient messaging was also automated, with up to three reminders sent to encourage patients to book an appointment, helping staff focus their time on non-responders. The process was then incorporated into the practice's existing blood testing routines with a clear workflow for HCAs, making DOAC monitoring easier to deliver consistently and evidence clearly.
What changed
Reliable DOAC monitoring at scale
With Abtrace, monitoring due dates and overdue patients are visible in one place, making it easier to spot gaps and address them promptly.
Pharmacist-led recall and consistent follow-up
With automated reminders and a clear process for reviewing patients who are still overdue, Abtrace helps the team follow up more consistently and reduces the need for manual chasing.
Data that sustains culture change
Clear dashboard analytics from Abtrace make progress easier to see, supporting staff confidence and helping the practice maintain performance over time.
Next steps
Woodbury Surgery plans to build on this approach by fine tuning its DOAC recall cadence and day-to-day workflow to help sustain progress over time. It also wants to extend the same pharmacist-led model to other high-risk medicines, using the learning from DOAC monitoring to support a consistent, practical approach across more areas of medicines safety.